ABIVAX (ABVX) Announces $90M Agreement to Repurchase Royalty Certificates

The ADSs were priced astatine $111.57 each, a fig based connected the five-day volume-weighted mean terms ending May 1. This determination aims to simplify the company’s superior operation and region a important royalty overhang up of aboriginal commercialization efforts. The issuance of shares to the certificate holders volition effect successful a insignificant dilution of ~0.5% of the company’s stock capital. Because the subscription terms for the offering is being paid via a set-off against the vendor’s indebtedness granted by the holders, ABIVAX volition not person immoderate caller currency proceeds from the transaction.

The offering and the cancellation of the royalty certificates are expected to adjacent astir May 7, taxable to customary closing conditions. Despite the $45 cardinal currency outlay, ABIVAX Société Anonyme (NASDAQ:ABVX) reported that its currency runway remains unchanged and is projected to past into Q4 2027. This fiscal position, supported by €530.4 cardinal successful currency and equivalents arsenic of precocious 2025, continues to money the company’s objective programs and pre-commercial planning.

ABIVAX Société Anonyme (NASDAQ:ABVX) develops therapeutics targeting chronic inflammatory diseases.

While we admit the imaginable of ABVX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy. 

Disclosure: None. Follow Insider Monkey connected Google News.